Morgan Stanley Ties Marred $1.3B Affymetrix Deal, Suit Says
An Affymetrix shareholder launched a putative class action in California federal court Wednesday, alleging the biotech's $1.3 billion buyout by Thermo Fisher resulted from a "truncated" sales process tainted by a...To view the full article, register now.
Already a subscriber? Click here to view full article